United Therapeutics (UTHR) Property, Plant & Equipment (Net) (2009 - 2026)
Powered by 
Analysis
United Therapeutics (UTHR) Property, Plant & Equipment (Net) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.43 Bn | 625.67 Bn | 17.26 Bn | 23.58 Bn |
| 2 | AbbVie | 442.46 Bn | 435.89 Bn | 12.70 Bn | 5.80 Bn |
| 3 | Merck | 366.77 Bn | 359.63 Bn | 12.21 Bn | 25.74 Bn |
| 4 | Novartis Ag | 266.59 Bn | 258.90 Bn | 11.24 Bn | 10.69 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | 19.03 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn | 113.37 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 34.61 Mn |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 709.47 Mn |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn | 1.93 Bn |
| 10 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | 90.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.93 Bn |
| Mar 31, 2026 | 1.84 Bn |
| Dec 31, 2025 | 1.73 Bn |
| Sep 30, 2025 | 1.56 Bn |
| Jun 30, 2025 | 1.36 Bn |
| Mar 31, 2025 | 1.30 Bn |
| Dec 31, 2024 | 1.22 Bn |
| Sep 30, 2024 | 1.16 Bn |
| Jun 30, 2024 | 1.09 Bn |
| Mar 31, 2024 | 1.07 Bn |
| Dec 31, 2023 | 1.07 Bn |
| Sep 30, 2023 | 992.20 Mn |
| Jun 30, 2023 | 938.90 Mn |
| Mar 31, 2023 | 896.50 Mn |
| Dec 31, 2022 | 883.70 Mn |
| Sep 30, 2022 | 840.80 Mn |
| Jun 30, 2022 | 791.40 Mn |
| Mar 31, 2022 | 784.40 Mn |
| Dec 31, 2021 | 780.90 Mn |
| Sep 30, 2021 | 726.70 Mn |